SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041196
Filing Date
2021-08-05
Accepted
2021-08-05 07:58:50
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q caba-10q_20210630.htm   iXBRL 10-Q 2836270
2 EX-31.1 caba-ex311_8.htm EX-31.1 21761
3 EX-31.2 caba-ex312_10.htm EX-31.2 22027
4 EX-32.1 caba-ex321_7.htm EX-32.1 10558
5 EX-32.2 caba-ex322_9.htm EX-32.2 10657
  Complete submission text file 0001564590-21-041196.txt   8322857

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA caba-20210630.xsd EX-101.SCH 41245
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caba-20210630_cal.xml EX-101.CAL 30821
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caba-20210630_def.xml EX-101.DEF 138542
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20210630_lab.xml EX-101.LAB 329745
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20210630_pre.xml EX-101.PRE 240741
11 EXTRACTED XBRL INSTANCE DOCUMENT caba-10q_20210630_htm.xml XML 1631246
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 211146386
SIC: 2836 Biological Products, (No Diagnostic Substances)